High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

1998-04-28

Human Reproduction , Volume 13 - Issue 3 p. 573- 575

Additional Metadata
Keywords	GnRH antagonists, Imminent ovarian hyperstimulation syndrome, In-vitro fertilization, Ovarian hyperstimulation syndrome
Persistent URL	doi.org/10.1093/humrep/13.3.573, hdl.handle.net/1765/65052
Journal	Human Reproduction
Organisation	Department of Gynaecology & Obstetrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Jong, D., Macklon, N., Mannaerts, B. M., Coelingh-Bennink, H. J. T., & Fauser, B. (1998). High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization. Human Reproduction, 13(3), 573–575. doi:10.1093/humrep/13.3.573

Publication